tiprankstipranks
Innate Pharma Hosts Immunotherapy Symposium
Company Announcements

Innate Pharma Hosts Immunotherapy Symposium

Innate Pharma SA (FR:IPH) has released an update.

Pick the best stocks and maximize your portfolio:

Innate Pharma SA is set to celebrate its 25th anniversary by hosting a hybrid scientific symposium on immunotherapy in collaboration with the Icahn School of Medicine at Mount Sinai. The event, titled ‘Next Generation Immunotherapy Discoveries,’ will feature leading experts in the field and take place both in-person in New York City and online on October 3, 2024. Prior to the symposium, Innate Pharma will conduct an Investor and Analyst Meeting to discuss the company’s therapeutic innovations.

For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyBiotech Alert: Searches spiking for these stocks today
TipRanks Auto-Generated NewsdeskInnate Pharma SA Reveals Promising Lacutamab Trial Results
TheFlyInnate Pharma announces new data from TELLOMAK study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App